Astellas Pharma, Inc. - Company & Market Research Reports

Home /
Companies /
Astellas Pharma, Inc.

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 119
Infectious Diseases Drugs 90
Endocrine and Metabolic Disorders Drugs 74
Central Nervous System Drugs 60
Genomics 59
Immune Disorders Drugs 57
Pharmaceuticals 44
Drug Discovery 42
Diabetes Drugs 42
Prostate Cancer Drugs 41
Vaccines 40
Biopharmaceuticals 37
Urological Disorders Drugs 35
Clinical Trials 34
Dermatological Drugs 33
Women's Health 32
Enzymes 30
Gastrointestinal Drugs 30
Biotechnology 28
Musculoskeletal Disorders Drugs 28
Cardiovascular Drugs 27
Liver and Kidney Disorders Drugs 26
Leukemia Drugs 24
Immunosuppressive Drugs 23
Antibiotics 21
Sexual and Reproductive Health Drugs 21
Optical Disorders Drugs 20
Allergy and Immunology 20
Surgical Procedures 20
Stem Cells 19
Oncology 19
Analgesics 18
Optical 14
Urology and Nephrology 13
Lung Cancer Drugs 13
Diagnostics 13
Medical Devices 13
Bladder Cancer Drugs 12
Infusions and Injectables 12
Drug Delivery 12
Dermatology 11
Healthcare Services 9
Respiratory Drugs 9
Pharmaceutical Manufacturing 9
Therapeutic Area 8
Neurology 8
Pulmonary Medicine 7
Lymphoma Drugs 7
Hearing Aids and Implants 7
Mental Disorders Drugs 7
Kidney Cancer Drugs 7
Gastroenterology 7
Pharmaceutical Intermediates 6
Biomaterials 6
Hematology 6
Over the Counter (OTC) Drugs 6
Proteomics 5
Managed Care 5
Needles and Syringes 5
Hematological Drugs 5
Allergy Drugs 5
Brain Cancer Drugs 4
Cardiovascular Devices 4
Infectious Disease Testing 4
Cancer Vaccines 4
Pancreatic Cancer Drugs 4
Company Reports 3
Drugs by Therapeutic Area 3
Colon Cancer Drugs 3
In Vitro Diagnostics 3
Mental Health 3
Pediatrics 3
Schizophrenia Drugs 3
Liver Cancer Drugs 2
Breast Cancer Drugs 2
Ovarian Cancer Drugs 2
Medical Imaging 2
Glucose Testing 2
Cough and Cold Drugs 2
Diabetes Devices 2
Transdermal and Transmucosal Drug Delivery 2
Biomarkers 2
Surgical Devices 2
Skin Cancer Drugs 2
Thyroid Cancer Drugs 2
Laboratory Equipment 2
Palliative Care 2
Cardiology 2
Asthma Drugs 2
Addiction Disorders Drugs 1
Patient Monitoring Equipment 1
E-Healthcare 1
Pharmacoeconomics 1
Fertility Services 1
Bioinformatics 1
Dialysis 1
Healthcare 1
Dental 1
Hospital Management 1
Alternative and Complementary Medicine 1
Molecular Diagnostics 1
Contrast Media 1
Nuclear Medicine and Radiopharmacology 1
Biosimilars and Biosuperiors 1
Nanomedicine 1
Anatomy 1
Acne Drugs 1
Alzheimer's Disease Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



283 reviews

1,133 Results (Page 45 of 57)
- Relevance
  Sort by

Persistent Facial Erythema Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
September 2024
89 Pages
Global

From

€3500EUR$4,251USD£3,141GBP

Sepsis Therapeutics Market 2024-2028

 Report
November 2023
157 Pages
Global

From

€2205EUR$2,500USD£1,912GBP

Viral and Non-Viral Vector Manufacturing Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3960EUR$4,490USD£3,434GBP

Gene Therapy Market - Forecasts from 2025 to 2030

 Report
August 2025
152 Pages
Global

From

€3484EUR$3,950USD£3,021GBP

Histoplasmosis Treatment Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3960EUR$4,490USD£3,434GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Sexually Transmitted Infections (STIs) Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3960EUR$4,490USD£3,434GBP

Urothelial Cancer Drugs Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3960EUR$4,490USD£3,434GBP

Head and Neck Cancer Therapeutics Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3960EUR$4,490USD£3,434GBP

Bone Cancer Treatment Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3960EUR$4,490USD£3,434GBP

Intestine Cancer Therapeutics Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3960EUR$4,490USD£3,434GBP

Checkpoint Inhibitors Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3960EUR$4,490USD£3,434GBP

Antibody Drug Conjugates Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3960EUR$4,490USD£3,434GBP

Nasopharyngeal Carcinoma Treatment Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3960EUR$4,490USD£3,434GBP

Alpha Receptor Antagonist - Pipeline Insight, 2025

 Clinical Trials
April 2025
120 Pages
Global

From

€1764EUR$2,000USD£1,530GBP

Chronic Obstructive Pulmonary Disorder Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2024
102 Pages
Global

From

€3500EUR$4,251USD£3,141GBP

Transplantation Market - Global Forecast 2026-2032

 Report
January 2026
182 Pages
Global

From

€3127EUR$3,545USD£2,711GBP

€3474EUR$3,939USD£3,012GBP

Cell Therapy Technologies Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3960EUR$4,490USD£3,434GBP

Immunology Market Analysis & Forecast 2024-2034: Market By Drug Class; By Indication; By Distribution Channel; and By Region

 Report
October 2023
145 Pages
Global

From

€2778EUR$3,150USD£2,409GBP

Spinal Muscular Atrophy - Pipeline Insight, 2025

 Clinical Trials
April 2025
80 Pages
Global

From

€1764EUR$2,000USD£1,530GBP

Blood Cancer Drugs Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3960EUR$4,490USD£3,434GBP

1,133 Results (Page 45 of 57)
- 1
- 43
- 44
- 45
- 46
- 47

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.